(ON-DEMAND ACOI 2025) Lipoprotein(a): The (Wholly Underappreciated) New Marker of Cardiovascular Risk

CME Credit Available:

This activity offers 0.5 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Explain the genetic determinants that influence lipoprotein(a) structure and plasma concentration.
• Describe how recent advances in translational biology have improved understanding of lipoprotein(a)’s role in cardiovascular disease.
• Evaluate emerging clinical trial data assessing novel therapies targeting lipoprotein(a) reduction.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert J. Chilton, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from January 1, 2026, until January 1, 2029.